diazonamide A

structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Harran, Patrick G: 3 articles (04/2015 - 07/2001)
2.	Burgett, Anthony W G: 2 articles (02/2007 - 07/2001)
3.	Caldwell, Charles G: 1 article (04/2015)
4.	DeRoy, Patrick L: 1 article (04/2015)
5.	Ding, Hui: 1 article (04/2015)
6.	Harran, Susan: 1 article (04/2015)
7.	Larivée, Alexandre: 1 article (04/2015)
8.	Perreault, Christian: 1 article (04/2015)
9.	Siddiqui, Arshad: 1 article (04/2015)
10.	Shang, Libin: 1 article (02/2007)

1.	Neoplasms (Cancer) 04/13/2015 - "This unique chemistry has enabled a concise, scalable preparation of DZ-2384; a refined analog of diazonamide A slated for clinical development as a cancer therapeutic. " 07/16/2001 - "Compositionally similar, yet topographically distinct, diazonamide A and 1 are both toxic towards cultured human cancer cells although the mechanisms underlying their actions likely differ. "
2.	Osteosarcoma (Osteogenic Sarcoma) 02/13/2007 - "We find that specific OAT knockdown in human cervical carcinoma and osteosarcoma cells by RNA interference blocks cell division and causes cell death, the effects largely phenocopying diazonamide A treatment in these cell lines. "
3.	Carcinoma (Carcinomatosis) 02/13/2007 - "We find that specific OAT knockdown in human cervical carcinoma and osteosarcoma cells by RNA interference blocks cell division and causes cell death, the effects largely phenocopying diazonamide A treatment in these cell lines. "